price
DM
NASDAQ · DMAC
DiaMedica Therapeutics Inc.
Healthcare · Biotechnology
$10.00
Up+$0.70 (+7.00%)
Updated Nov 4, 2026, 7:46 PM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 486.92M
- P/E ratio
- -13.58
- Dividend yield
- 0.00%
- 52-week range
- $5.25 – $10.13
- Volume
- 302.42K
- Avg. volume
- 389.45K
Price performance · DMAC
DMAC price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
DMAC closed at $10.00 after 21 trading sessions, up 23.00% for the selected period.
- Last close
- $10.00
- Period change
- +23.00%
- Period low
- $7.57
- Period high
- $10.00
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $9.38 | $10.04 | $9.38 | $10.00 | 302.42K |
| Nov 2, 2026 | $9.33 | $9.505 | $8.96 | $9.29 | 141.54K |
| Oct 30, 2026 | $9.39 | $9.54 | $9.12 | $9.25 | 174.65K |
| Oct 29, 2026 | $9.83 | $9.99 | $9.41 | $9.52 | 196.51K |
| Oct 28, 2026 | $8.71 | $10.13 | $8.60 | $9.82 | 521.28K |
| Oct 27, 2026 | $8.72 | $8.72 | $8.30 | $8.69 | 268.72K |
| Oct 26, 2026 | $8.77 | $8.92 | $8.56 | $8.74 | 129.6K |
| Oct 23, 2026 | $8.55 | $8.79 | $8.29 | $8.72 | 110.03K |
| Oct 22, 2026 | $8.70 | $8.9464 | $8.51 | $8.63 | 87.99K |
| Oct 21, 2026 | $8.72 | $8.95 | $8.59 | $8.69 | 155.38K |
| Oct 20, 2026 | $7.88 | $8.87 | $7.88 | $8.67 | 168.17K |
| Oct 19, 2026 | $7.78 | $7.99 | $7.60 | $7.87 | 188.58K |
| Oct 16, 2026 | $8.04 | $8.10 | $7.53 | $7.57 | 260.78K |
| Oct 15, 2026 | $7.82 | $8.24 | $7.66 | $8.04 | 303.89K |
| Oct 14, 2026 | $7.68 | $8.02 | $7.61 | $7.66 | 286.96K |
| Oct 13, 2026 | $8.21 | $8.21 | $7.72 | $7.82 | 256.05K |
| Oct 12, 2026 | $8.26 | $8.335 | $7.945 | $8.20 | 185.59K |
| Oct 9, 2026 | $8.00 | $8.4499 | $8.00 | $8.33 | 170.15K |
| Oct 8, 2026 | $7.92 | $8.06 | $7.66 | $8.01 | 240.27K |
| Oct 7, 2026 | $8.01 | $8.415 | $7.95 | $7.99 | 221.23K |
| Oct 6, 2026 | $8.50 | $8.61 | $8.05 | $8.13 | 242.32K |
Latest DMAC news
The latest Smart Investors Daily articles mentioning DMAC.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…

